BEXFX
Price
$14.75
Change
-$0.21 (-1.40%)
Updated
Sep 6 closing price
RNWFX
Price
$79.55
Change
-$1.12 (-1.39%)
Updated
Sep 6 closing price
Ad is loading...

BEXFX vs RNWFX

Header iconBEXFX vs RNWFX Comparison
Open Charts BEXFX vs RNWFXBanner chart's image
Baron Emerging Markets Retail
Price$14.75
Change-$0.21 (-1.40%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$79.55
Change-$1.12 (-1.39%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
BEXFX vs RNWFX Comparison Chart
Loading...
VS
BEXFX vs. RNWFX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEXFX is a StrongSell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.1B vs. BEXFX (3.93B). RNWFX pays higher dividends than BEXFX: RNWFX (1.51) vs BEXFX (0.41). BEXFX was incepted earlier than RNWFX: BEXFX (14 years) vs RNWFX (22 years). BEXFX (33.37) and RNWFX (32.00) have comparable annual turnover. RNWFX has a lower initial minimum investment than BEXFX: RNWFX (250) vs BEXFX (2000). RNWFX annual gain was more profitable for investors over the last year : 11.53 vs. BEXFX (10.72). RNWFX return over 5 years is better than : 22.38 vs. BEXFX (12.36).
BEXFXRNWFXBEXFX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years22 years-
Gain YTD7.3947.245102%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets3.93B60.1B7%
Annual Yield % from dividends0.411.5127%
Returns for 1 year10.7211.5393%
Returns for 3 years-20.93-15.44136%
Returns for 5 years12.3622.3855%
Returns for 10 years21.5935.7160%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGO16.410.29
+1.80%
Eldorado Gold Corp
BIP31.38-0.08
-0.25%
Brookfield Infrastructure Partners LP
KTRA0.17N/A
-2.51%
Kintara Therapeutics
LCTX0.87-0.03
-3.17%
Lineage Cell Therapeutics
NUVB2.88-0.13
-4.32%
Nuvation Bio